0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Drug/Vaccine Safety
 61-80 of 634 Articles
JAMA Internal Medicine | 
Original Investigation | 
Ajit A. Dhavle, PharmD, MBA; Yuze Yang, PharmD; Michael T. Rupp, PhD; et al.
JAMA Intern Med. 2016;176(4):463-470. doi:10.1001/jamainternmed.2015.7786.

JAMA Internal Medicine | 
Invited Commentary | 
Michael A. Steinman, MD
JAMA Intern Med. 2016;176(4):482-483. doi:10.1001/jamainternmed.2015.8597.

JAMA Internal Medicine | 
Original Investigation | 
Dima M. Qato, PharmD, MPH, PhD; Jocelyn Wilder, MPH; L. Philip Schumm, MA; et al.
JAMA Intern Med. 2016;176(4):473-482. doi:10.1001/jamainternmed.2015.8581.
Includes: Supplemental Content

JAMA Cardiology | 
Original Investigation |  FREE
John A. Dodson, MD, MPH; Andrew Petrone, MPH; David R. Gagnon, MD, MPH, PhD; et al.
JAMA Cardiol. 2016;1(1):65-72. doi:10.1001/jamacardio.2015.0345.
Includes: Supplemental Content

JAMA Oncology | 
Original Investigation |  Open Access
Nicholas D. James, PhD, FRCR, FRCP; Sarah J. Pirrie, MSc; Ann M. Pope, PhD; et al.
JAMA Oncol. 2016;2(4):493-499. doi:10.1001/jamaoncol.2015.5570.
Includes: Supplemental Content

JAMA Oncology | 
Editorial | 
Michael Kolinsky, BSc, MD; Pasquale Rescigno, MD; Johann S. de Bono, MB, ChB, MSc, FRCP, PhD, FMedSci
JAMA Oncol. 2016;2(4):437-438. doi:10.1001/jamaoncol.2015.4918.

JAMA Oncology | 
Invited Commentary | 
Saroj Niraula, MBBS, MD, MSc; Ian F. Tannock, MD, PhD
JAMA Oncol. 2016;2(4):461-462. doi:10.1001/jamaoncol.2015.4682.

JAMA Oncology | 
Original Investigation | 
Dawn L. Hershman, MD, MS; Joseph M. Unger, PhD; Jason D. Wright, MD; et al.
JAMA Oncol. 2016;2(4):453-461. doi:10.1001/jamaoncol.2015.4655.
Includes: Supplemental Content

JAMA Surgery | 
Research Letter | 
William Toppen, BA; Sohail Sareh, MS; Daniel Johansen, BA; et al.
JAMA Surg. 2016;151(4):389-391. doi:10.1001/jamasurg.2015.4212.

JAMA Dermatology | 
Research Letter |  ONLINE FIRST
Simone M. Goldinger, MD; Sharon Gobbi Bischof, MD; Regina Fink-Puches, MD; et al.
JAMA Dermatol. Published online March 23, 2016. doi:10.1001/jamadermatol.2016.0401

JAMA | 
Capitol Health Call | 
Rita Rubin, MA
JAMA. 2016;315(10):970. doi:10.1001/jama.2016.1783.

JAMA | 
News From the Centers for Disease Control and Prevention | 
JAMA. 2016;315(10):971. doi:10.1001/jama.2016.1631.

JAMA Internal Medicine | 
Viewpoint | 
Amy Kapczynski, JD
JAMA Intern Med. 2016;176(3):295-296. doi:10.1001/jamainternmed.2015.8155.

JAMA Dermatology | 
Editorial | 
Matthew H. Kanzler, MD
JAMA Dermatol. 2016;152(3):263-264. doi:10.1001/jamadermatol.2015.4203.

JAMA Dermatology | 
Original Investigation | 
Anar Mikailov, MD; Jeffrey Cohen, MD; Cara Joyce, PhD; et al.
JAMA Dermatol. 2016;152(3):276-281. doi:10.1001/jamadermatol.2015.4190.
Includes: Supplemental Content

JAMA Internal Medicine | 
Research Letter | 
Christopher M. Jones, PharmD, MPH; Peter G. Lurie, MD, MPH; Douglas C. Throckmorton, MD
JAMA Intern Med. 2016;176(3):399-402. doi:10.1001/jamainternmed.2015.7799.

JAMA Pediatrics | 
Viewpoint | 
Adam L. Hersh, MD, PhD; Jason G. Newland, MD, MEd; Jeffrey S. Gerber, MD, PhD
JAMA Pediatr. 2016;170(3):191-192. doi:10.1001/jamapediatrics.2015.3369.

JAMA Oncology | 
Invited Commentary | 
David Cella, PhD
JAMA Oncol. 2016;2(3):368-369. doi:10.1001/jamaoncol.2015.4683.

JAMA Oncology | 
Research Letter | 
Nabil Adra, MD; Hamid Sayar, MD; Lawrence H. Einhorn, MD
JAMA Oncol. 2016;2(3):391-392. doi:10.1001/jamaoncol.2015.4837.

JAMA Dermatology | 
Research Letter | 
Kai-Lung Chen, MD; Chia-Chi Lin, MD, PhD; Yung-Tsu Cho, MD; et al.
JAMA Dermatol. 2016;152(3):340-342. doi:10.1001/jamadermatol.2015.4448.

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Invited Commentary  | 
Cardiac Protection in HER2-Targeted Treatment How Should We Measure New Strategies?
Ana Barac, MD, PhD; Sandra M. Swain, MD
JAMA Oncology
Original Investigation  | 
Angiotensin II–Receptor Inhibition With Candesartan to Prevent Trastuzumab-Related Cardiotoxic Effects in Patients With Early Breast Cancer A Randomized Clinical Trial
Annelies H. Boekhout, PhD; Jourik A. Gietema, MD, PhD; Bojana Milojkovic Kerklaan, PhD; et al.
JAMA
News From the Food and Drug Administration  | 
Olanzapine Linked With Potentially Fatal Skin Reaction
Rebecca Voelker, MSJ
JAMA Psychiatry
Original Investigation  | 
Efficacy and Safety of Basimglurant as Adjunctive Therapy for Major Depression A Randomized Clinical Trial
Jorge A. Quiroz, MD, MBA; Paul Tamburri, PharmD; Dennis Deptula, PhD; et al.